Risks Associated With Benzodiazepine Long‐Term Use in Chronic Insomnia: A Systematic Review and (Network) Meta‐Analysis
Dieter Riemann, Chiara Baglioni, Christoph Nissen, Agathe Nevière, Omar Irfan, Pauline Le Nouveau, Chrysoula Leontiou, Damien Léger · 2026
Read Risks Associated With Benzodiazepine Long‐Term Use in Chronic Insomnia: A Systematic Review and (Network) Meta‐Analysis by Dieter Riemann, Chiara Baglioni, Christoph Nissen, Agathe Nevière, Omar Irfan, Pauline Le Nouveau, Chrysoula Leontiou, Damien Léger (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13619061.txt.
Description
Dieter Riemann and seven colleagues review the risks of benzodiazepine sleeping pills taken for more than three months, in a 2026 analysis with meta-analyses where data allowed. Guidelines warn against use beyond four weeks because of dependence and side effects. Yet long prescriptions remain common. Twenty-seven studies from 1987 to 2023 met their criteria, and five outcomes, insomnia severity, sleep quality, falls, depression, and anxiety, could be pooled.
Long-term users slept worse than healthy sleepers but better than unmedicated insomnia patients, a pattern reflecting who gets prescribed these drugs. Fall risk did not differ between users and non-users. Depression and anxiety ran higher in users than in healthy sleepers. The reviewers stress how few such studies exist. The available evidence suggests extended use may erode sleep, mental health, and quality of life. Their conclusion backs guideline advice: keep courses short, with behavioral therapy and safer alternatives first.
Catalog record
| CREATOR | Dieter Riemann, Chiara Baglioni, Christoph Nissen, Agathe Nevière, Omar Irfan, Pauline Le Nouveau, Chrysoula Leontiou, Damien Léger |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 82616 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |